Mello, D.B.; Mesquita, F.C.P.; Silva dos Santos, D.; Asensi, K.D.; Dias, M.L.; Campos de Carvalho, A.C.; Goldenberg, R.C.d.S.; Kasai-Brunswick, T.H.
Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options. Int. J. Mol. Sci. 2024, 25, 6063.
https://doi.org/10.3390/ijms25116063
AMA Style
Mello DB, Mesquita FCP, Silva dos Santos D, Asensi KD, Dias ML, Campos de Carvalho AC, Goldenberg RCdS, Kasai-Brunswick TH.
Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options. International Journal of Molecular Sciences. 2024; 25(11):6063.
https://doi.org/10.3390/ijms25116063
Chicago/Turabian Style
Mello, Debora B., Fernanda Cristina Paccola Mesquita, Danúbia Silva dos Santos, Karina Dutra Asensi, Marlon Lemos Dias, Antonio Carlos Campos de Carvalho, Regina Coeli dos Santos Goldenberg, and Tais Hanae Kasai-Brunswick.
2024. "Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options" International Journal of Molecular Sciences 25, no. 11: 6063.
https://doi.org/10.3390/ijms25116063
APA Style
Mello, D. B., Mesquita, F. C. P., Silva dos Santos, D., Asensi, K. D., Dias, M. L., Campos de Carvalho, A. C., Goldenberg, R. C. d. S., & Kasai-Brunswick, T. H.
(2024). Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options. International Journal of Molecular Sciences, 25(11), 6063.
https://doi.org/10.3390/ijms25116063